We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Proteins in Cell Nuclear Membrane Actively Influence Gene Expression

By Gerald M. Slutzky, PhD
Posted on 15 Nov 2016
A team of cell biologists has brought to light new information as to how proteins in the nuclear membrane act to regulate the expression of genes that determine how a cell functions and what role it plays in the organism.

The nucleoporins are a family of proteins in the membrane of the cell nucleus, which are the constituent building blocks of the nuclear pore complex (NPC). More...
The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the cell nucleus and the cytoplasm. Nuclear pores in turn allow the transport of water-soluble molecules across the nuclear envelope. Nucleoporins, a family of around 30 proteins, are the main components of the nuclear pore complex in eukaryotic cells.

The organization of the genome in the three-dimensional space of the nucleus is coupled with cell type-specific gene expression. However, how nuclear architecture influences transcription that governs cell identity remains unknown. A recent paper in the November 2, 2016, online edition of the journal Genes & Development has described a crucial role of NPC components in the regulation of cell type-specifying genes and highlighted nuclear architecture as a regulatory layer of genome functions in cell fate.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) employed a technique called DamID to determine where two nucleoporins, Nup153 and Nup93, came into contact with the genome in a human bone cancer cell line. DamID (DNA adenine methyltransferase identification) is a molecular biology protocol used to map the binding sites of DNA- and chromatin-binding proteins in eukaryotes. DamID identifies binding sites by expressing the proposed DNA-binding protein as a fusion protein with DNA methyltransferase. Binding of the protein of interest to DNA localizes the methyltransferase in the region of the binding site. Adenosine methylation does not occur naturally in eukaryotes and therefore adenine methylation in any region can be concluded to have been caused by the fusion protein, implying the region is located near a binding site.

Results revealed that the NPC components Nup93 and Nup153 bound to superenhancers (SE), which are regulatory structures that drive the expression of key genes that specify cell identity. Nucleoporin-associated SEs localized preferentially to the nuclear periphery, and the absence of Nup153 and Nup93 resulted in dramatic transcriptional changes of SE-associated genes.

"Our research shows that, far from being a passive enclosure as many biologists have thought, the nuclear membrane is an active regulatory structure," said senior author Dr. Martin W. Hetzer, research professor at the Salk Institute for Biological Studies. "Not only does it interact with portions of the genome to drive gene expression, but it can also contribute to disease processes when components are faulty. People have thought the nuclear membrane is just a protective barrier, which is maybe the reason why it evolved in the first place. But there are many more regulatory levels that we do not understand. And it is such an important area because so far, every membrane protein that has been studied and found to be mutated or mis-localized, seems to cause a human disease."

Related Links:
Salk Institute for Biological Studies


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.